Gabriel Cohn - Jan 1, 2022 Form 4 Insider Report for Homology Medicines, Inc. (FIXX)

Role
Chief Medical Officer
Signature
/s/ W. Bradford Smith, Attorney-in-Fact for Gabriel Cohn
Stock symbol
FIXX
Transactions as of
Jan 1, 2022
Transactions value $
-$6,279
Form type
4
Date filed
1/12/2022, 03:05 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FIXX Common Stock Options Exercise +4.29K 4.29K Jan 1, 2022 Direct F1
transaction FIXX Common Stock Sale -$6.28K -1.66K -38.72% $3.78 2.63K Jan 5, 2022 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FIXX Restricted Stock Units Options Exercise $0 -4.29K -33% $0.00 8.71K Jan 1, 2022 Common Stock 4.29K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
F2 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs.
F3 The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.79. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3.
F4 The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date.